Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity

scientific article published on 01 November 2006

Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1037111371
P356DOI10.1007/S00268-006-0038-0
P698PubMed publication ID17006608

P50authorAlessandro NeriQ41617212
Daniele MarrelliQ56420365
P2093author name stringFranco Roviello
Giovanni de Manzoni
Enrico Pinto
Daniela Cerretani
Corrado Pedrazzani
Giorgio Giorgi
Giacomo Nastri
Tommaso Cioppa
P2860cites workCytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancerQ80033156
Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal studyQ81181178
Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter studyQ81271475
Pharmacokinetics of mitomycin C after resection of peritoneal carcinomatosis and intraperitoneal chemohyperthermic perfusionQ82354889
Peritonectomy proceduresQ34316366
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinomaQ35648472
Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermiaQ35721975
Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategiesQ36375924
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.Q40698258
A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: different mechanisms in peritoneal dissemination and hematogenous metastasisQ40865400
Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapyQ41134502
Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal originQ43596237
Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancerQ43999297
Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapyQ44750686
Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapyQ45218465
Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusionQ45288550
Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancerQ50169032
Treatment of peritoneal carcinomatosis with intent to cure.Q52167494
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.Q53286355
Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.Q53636347
Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion.Q53846044
The Value of Peritoneal Cytology as a Preoperative Predictor in Patients With Gastric Carcinoma Undergoing a Curative ResectionQ57846301
Bowel Complications in 203 Cases of Peritoneal Surface Malignancies Treated With Peritonectomy and Closed-Technique Intraperitoneal Hyperthermic PerfusionQ61848909
Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis Arising From Colon AdenocarcinomaQ62711405
Pathobiology of peritoneal carcinomatosis from ovarian malignancyQ71600165
Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II studyQ73063070
Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgeryQ73090921
Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinomaQ73097148
Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed managementQ73125898
Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum techniqueQ73327596
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective studyQ73368601
Prospective study of peritoneal recurrence after curative surgery for gastric cancerQ73876936
Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal studyQ74713453
Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancerQ75244449
Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled studyQ77553200
Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive proceduresQ79121171
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal CancerQ79150738
P433issue11
P921main subjectperitoneal carcinomatosisQ2071182
P304page(s)2033-40; discussion 2041-2
P577publication date2006-11-01
P1433published inWorld Journal of SurgeryQ15763279
P1476titleTreatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity
P478volume30

Reverse relations

cites work (P2860)
Q92996834Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study
Q50545083Care of Pediatric Oncology Patients After Continuous Hyperthermic Peritoneal Perfusion
Q33634993Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
Q42863985Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer
Q37094755Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis
Q37413266Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei
Q36160064Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details
Q87374662Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution
Q51139020Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites.
Q42110220Enterocutaneous fistula associated with malignancy and prior radiation therapy
Q84474601Gastric linitis plastica: which role for surgical resection?
Q42924756Impact of the hyperthermic intraperitoneal chemotherapy on the fluid-electrolytes changes and on the acid-base balance
Q35957129Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures
Q50761729Metastatic adenocarcinomas of the stomach or esophagogastric junction (UICC stage IV) are not always a palliative situation: a retrospective analysis.
Q37658497Morbidity and mortality of 109 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC) performed at a community hospital
Q57280119Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in advanced gastric cancer
Q64055171Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study
Q34391090Peritoneal carcinomatosis of colorectal origin.
Q34366940Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?
Q34391112Peritoneal carcinosis of ovarian origin.
Q28067269Regional but fatal: Intraperitoneal metastasis in gastric cancer
Q38201470The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art.

Search more.